Iomai Corporation , Nasdaq: IOMI
Develops vaccines and immunostimulants delivered to the skin.
Industry: Health Care
First Day Return: -2.9%
Industry: Health Care
IOMI
Develops vaccines and immunostimulants delivered to the skin.
| IPO Data | |
|---|---|
| IPO File Date | 10/03/2005 |
| Offer Price | $7.00 |
| Price Range $11.00 - $13.00 | |
| Offer Shares (mm) | 5.0 |
| Deal Size ($mm) | $35 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 01/31/2006 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $35 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Gaithersburg, MD, United States |
| Founded | 1997 |
| Employees at IPO | 53 |
| Website www.iomai.com | |
IPO News for Iomai Corporation
Iomai Corporation (IOMI) Performance
